Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M.-J. Zhu
Phase II Study of Neoadjuvant Imatinib in Glioblastoma: Evaluation of Clinical and Molecular Effects of the Treatment
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Multicenter Phase II Clinical Trial of Nilotinib for Patients With Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia From the East Japan CML Study Group Evaluation of Molecular Response and the Efficacy and Safety of Nilotinib
Biomarker Research
Biochemistry
Molecular Medicine
Clinical Biochemistry
A Phase II Study of Cetuximab, Capecitabine and Radiotherapy in Neoadjuvant Treatment of Patients With Locally Advanced Resectable Rectal Cancer
European Journal of Surgical Oncology
Medicine
Oncology
Surgery
Phase II Pilot Study of Imatinib Mesylate for the Treatment of Severe Sclerotic Skin Chronic Graft Versus Host Disease (ScGVHD)
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Phase II Trial of Neoadjuvant Pemetrexed Plus Cisplatin Followed by Surgery and Radiation in the Treatment of Pleural Mesothelioma
BMC Cancer
Cancer Research
Oncology
Genetics
P2.17-27 IMpower030: Phase III Study Evaluating Neoadjuvant Treatment of Resectable Stage II-IIIB NSCLC With Atezolizumab + Chemotherapy
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Comparative Evaluation of Clinical Response and Toxicities Between Neoadjuvant Chemoradiation Versus Radiation Alone in the Treatment of Advanced Stage (Stage II and III) of Rectal Carcinoma
Journal of Medical Science And clinical Research
Glioblastoma Update: Molecular Biology, Diagnosis, Treatment, Response Assessment, and Translational Clinical Trials
F1000Research
Genetics
Molecular Biology
Pharmacology
Biochemistry
Microbiology
Immunology
Medicine
Toxicology
Pharmaceutics
Molecular and Clinical Insights Into the Invasive Capacity of Glioblastoma Cells
Journal of Oncology
Oncology
Imatinib and Everolimus in Patients With Progressing Advanced Chordoma: A Phase 2 Clinical Study
Cancer
Cancer Research
Oncology